| Date Filed | Type | Description |
| 08/15/2023 |
4
| Pera Antonio R (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 3,000 shares
@ $60.37, valued at
$181.1k
|
|
| 05/24/2023 |
4
| Pera Antonio R (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 6,865 shares
@ $0 |
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2019 |
4
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 11,669 shares
@ $8.1, valued at
$94.5k
|
|
| 04/02/2019 |
4
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Granted 46,973 shares
@ $0 |
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2018 |
4
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 5,585 shares
@ $15.82, valued at
$88.4k
|
|
| 04/04/2018 |
4
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Granted 109,523 shares
@ $0 |
|
| 02/27/2018 |
4
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 194 shares
@ $6.78, valued at
$1.3k
|
|
| 02/22/2018 |
4
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 4 on Endo International plc|
Txns:
| Paid exercise price by delivering 3,117 shares
@ $6.72, valued at
$20.9k
|
|
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/08/2016 |
3
| Pera Antonio R (President, Par Pharmaceutical) has filed a Form 3 on Endo International plc |